PT784486E - Inerleucina-12 como um adjuvante para vacinas contra paramyxoviridae - Google Patents
Inerleucina-12 como um adjuvante para vacinas contra paramyxoviridaeInfo
- Publication number
- PT784486E PT784486E PT95938133T PT95938133T PT784486E PT 784486 E PT784486 E PT 784486E PT 95938133 T PT95938133 T PT 95938133T PT 95938133 T PT95938133 T PT 95938133T PT 784486 E PT784486 E PT 784486E
- Authority
- PT
- Portugal
- Prior art keywords
- virus
- paramyxoviridae family
- parainfluenza
- inerleukin
- adjuvant
- Prior art date
Links
- 241000711504 Paramyxoviridae Species 0.000 title abstract 5
- 239000002671 adjuvant Substances 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 10
- 102000013462 Interleukin-12 Human genes 0.000 abstract 4
- 108010065805 Interleukin-12 Proteins 0.000 abstract 4
- 208000002606 Paramyxoviridae Infections Diseases 0.000 abstract 4
- 229940117681 interleukin-12 Drugs 0.000 abstract 4
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 241000711404 Avian avulavirus 1 Species 0.000 abstract 1
- 241000711895 Bovine orthopneumovirus Species 0.000 abstract 1
- 241000712083 Canine morbillivirus Species 0.000 abstract 1
- 241000712079 Measles morbillivirus Species 0.000 abstract 1
- 241000712045 Morbillivirus Species 0.000 abstract 1
- 241000711902 Pneumovirus Species 0.000 abstract 1
- 241000725643 Respiratory syncytial virus Species 0.000 abstract 1
- 230000029812 viral genome replication Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55538—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31848094A | 1994-10-05 | 1994-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT784486E true PT784486E (pt) | 2006-07-31 |
Family
ID=23238354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT95938133T PT784486E (pt) | 1994-10-05 | 1995-10-02 | Inerleucina-12 como um adjuvante para vacinas contra paramyxoviridae |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6071893A (pt) |
| EP (1) | EP0784486B1 (pt) |
| JP (1) | JP3939752B2 (pt) |
| AT (1) | ATE322289T1 (pt) |
| AU (1) | AU701753B2 (pt) |
| DE (1) | DE69534922T2 (pt) |
| DK (1) | DK0784486T3 (pt) |
| ES (1) | ES2257744T3 (pt) |
| MX (1) | MX9702396A (pt) |
| PT (1) | PT784486E (pt) |
| WO (1) | WO1996011019A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3737519B2 (ja) * | 1996-05-31 | 2006-01-18 | ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー | 百日咳菌ワクチン用アジュバントとしてのｉｌ―１２ |
| GB9712347D0 (en) | 1997-06-14 | 1997-08-13 | Smithkline Beecham Biolog | Vaccine |
| AU759391B2 (en) * | 1998-02-12 | 2003-04-10 | Wyeth Holdings Corporation | Pneumococcal and meningococcal vaccines formulated with interleukin-12 |
| EP1053016A2 (en) * | 1998-02-12 | 2000-11-22 | American Cyanamid Company | Vaccines comprising interleukin-12 and respiratory syncytial viral antigens |
| US6814968B1 (en) | 1998-06-04 | 2004-11-09 | Vanderbilt University | Inhibition of viral infection and spread with viral and RhoA-derived peptides |
| WO2000069456A2 (en) * | 1999-05-13 | 2000-11-23 | American Cyanamid Company | Adjuvant combination formulations |
| US7374751B1 (en) | 2000-06-22 | 2008-05-20 | Wyeth Holdings Corporation | QS-21 and IL-12 as an adjuvant combination |
| HUP0600589A2 (en) * | 2000-11-10 | 2006-11-28 | Wyeth Corp | Adjuvant combination formulations |
| US20030129161A1 (en) * | 2001-09-17 | 2003-07-10 | Hsien-Jue Chu | Interleukin-12 as a veterinary vaccine adjuvant |
| US20090227025A1 (en) * | 2003-06-06 | 2009-09-10 | The Board Of Regents Of The University Of Texas System | Ex vivo human lung/immune system model using tissue engineering for studying microbial pathogens with lung tropism |
| CN113304158B (zh) * | 2021-06-10 | 2022-10-28 | 山东省农业科学院畜牧兽医研究所 | 磺胺甲氧吡嗪在制备预防和/或治疗牛副流感病毒产品中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223254A (en) * | 1987-09-29 | 1993-06-29 | Praxis Biologics, Inc. | Respiratory syncytial virus: vaccines |
| GB8914968D0 (en) * | 1989-06-29 | 1989-08-23 | Connaught Lab | Production of virus and purification of viral envelope proteins for vaccine use |
| TW275632B (pt) * | 1992-04-21 | 1996-05-11 | American Cyanamid Co | |
| EP0604727A1 (en) * | 1992-12-31 | 1994-07-06 | American Cyanamid Company | Improved immunogenicity of a vaccine by incorporation of a cytokine within an immune-stimulating complex containing an antigen |
| ATE196737T1 (de) * | 1993-05-25 | 2000-10-15 | American Cyanamid Co | Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus |
| US5830463A (en) * | 1993-07-07 | 1998-11-03 | University Technology Corporation | Yeast-based delivery vehicles |
| US7223410B1 (en) * | 1994-08-05 | 2007-05-29 | Sanofi Pasteur Limited | Inactivated respiratory syncytial viral vaccines |
| US5571515A (en) * | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
| ZA953703B (en) * | 1994-05-10 | 1996-01-10 | American Home Prod | Modified live BRSV vaccine |
-
1995
- 1995-10-02 DE DE69534922T patent/DE69534922T2/de not_active Expired - Lifetime
- 1995-10-02 DK DK95938133T patent/DK0784486T3/da active
- 1995-10-02 PT PT95938133T patent/PT784486E/pt unknown
- 1995-10-02 ES ES95938133T patent/ES2257744T3/es not_active Expired - Lifetime
- 1995-10-02 AT AT95938133T patent/ATE322289T1/de not_active IP Right Cessation
- 1995-10-02 EP EP95938133A patent/EP0784486B1/en not_active Expired - Lifetime
- 1995-10-02 AU AU38876/95A patent/AU701753B2/en not_active Ceased
- 1995-10-02 JP JP51263596A patent/JP3939752B2/ja not_active Expired - Fee Related
- 1995-10-02 WO PCT/US1995/012656 patent/WO1996011019A1/en active IP Right Grant
- 1995-10-02 MX MX9702396A patent/MX9702396A/es not_active IP Right Cessation
-
1997
- 1997-11-26 US US08/980,160 patent/US6071893A/en not_active Expired - Fee Related
-
2006
- 2006-12-01 US US11/607,073 patent/US20070087016A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU3887695A (en) | 1996-05-02 |
| DE69534922T2 (de) | 2006-11-23 |
| MX9702396A (es) | 1997-12-31 |
| ATE322289T1 (de) | 2006-04-15 |
| US6071893A (en) | 2000-06-06 |
| ES2257744T3 (es) | 2006-08-01 |
| JP3939752B2 (ja) | 2007-07-04 |
| EP0784486A1 (en) | 1997-07-23 |
| EP0784486B1 (en) | 2006-04-05 |
| US20070087016A1 (en) | 2007-04-19 |
| DK0784486T3 (da) | 2006-08-14 |
| DE69534922D1 (en) | 2006-05-18 |
| AU701753B2 (en) | 1999-02-04 |
| JPH10507175A (ja) | 1998-07-14 |
| WO1996011019A1 (en) | 1996-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT784486E (pt) | Inerleucina-12 como um adjuvante para vacinas contra paramyxoviridae | |
| HRP20050192B1 (hr) | Cjepivo za infekcije dišnog i spolnog sustava kod goveda | |
| DE69628834D1 (de) | Virus impfstoff | |
| AU711350B2 (en) | Improved modified live BRSV vaccine | |
| RU2400248C2 (ru) | ПОЛИВАЛЕНТНЫЕ ВАКЦИНЫ ДЛЯ СОБАК ПРОТИВ Leptospira bratislava И ДРУГИХ ПАТОГЕНОВ | |
| JP4020431B2 (ja) | 生ワクチンの安定化剤 | |
| SI2762163T1 (en) | Procedures for administration of the vaccine | |
| RU2005128790A (ru) | Модифицированные живые вакцины, содержащие вирус бычьего герпеса типа 1 (bhv-1(ibr)) и/или вирус бычьей вирусной диареи (bvdv), для беременных и вскармливаемых особей скота | |
| AR042935A1 (es) | Vacunas caninas contra bordetella bronchiseptica | |
| Prince et al. | Immunoprotective Activity and Safety of a RespiratorySyncytial Virus Vaccine: Mucosal Delivery of Fusion Glycoprotein with aCpG OligodeoxynucleotideAdjuvant | |
| RU2006133328A (ru) | Способ вакцинации против инфекции семенников bvdv | |
| Edwards et al. | Evidence for an immunocompromising effect of bovine pestivirus on bovid herpesvirus 1 vaccination | |
| OTTOLINI et al. | Enhanced pulmonary pathology in cotton rats upon challenge after immunization with inactivated parainfluenza virus 3 vaccines | |
| AR016987A1 (es) | Composiciones acuosas de vacuna acuosaa para la profilaxis de hepatitis b o hepatitis b/a | |
| ZIOLA et al. | T cell cross-reactivity among viruses of the paramyxoviridae | |
| GB1059095A (en) | Interferential vaccines | |
| Panigrahi et al. | Structural proteins of bovine parainfluenza-3 virus | |
| Beale | Measles vaccines | |
| Basaraba | Mechanisms of in vitro immunosuppression by bovine parainfluenza virus type 3 | |
| WO2002011761A2 (en) | Vaccine against rsv | |
| Bahri et al. | Protective antibody titre against Newcastle disease in ostriches (Struthio camelus) | |
| Harmeyer et al. | Five day onset of protection and for 12 weeks after single intranasal vaccination of one-week-old calves with a modified live BRSV vaccine after experimental BRSV challenge. | |
| DOP2003000699A (es) | Vacunas para enfermedades reproductoras del ganado | |
| MXPA96005503A (en) | Improved vaccine of sinbotial virus respiratory debovino (brsv) live, modification |